Reason for request
Re-assessment of Actual Benefit in compliance with article R. 163-21 of the French Social Security Code.
Clinical Benefit
| Insufficient |
The Committee considers that the actual benefit of AVANDIA and AVANDAMET products is now insufficient for it to be paid for by National Health Insurance, in comparison with existing therapies. |
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
UHwAthLXhamPybF0
